Literature DB >> 11507051

Instabilotyping: comprehensive identification of frameshift mutations caused by coding region microsatellite instability.

Y Mori1, J Yin, A Rashid, B A Leggett, J Young, L Simms, P M Kuehl, P Langenberg, S J Meltzer, O C Stine.   

Abstract

Coding region frameshift mutation caused by microsatellite instability (MSI) is one mechanism contributing to tumorigenesis in cancers with MSI in high frequency. Mutation of TGFBR2 is one example of this process. To identify additional examples, a large-scale genomic screen of coding region microsatellites was conducted. 1115 coding homopolymeric loci with six or more nucleotides were identified in an online genetic database. Mutational screening was performed at 152 of these loci in 46 colorectal tumors with MSI in high frequency. Nine loci were mutated in > or =20% of tumors, 10 loci in 10-20%, 24 loci in 5-10%, 43 loci in <5%, and 66 loci were not mutated in any tumors. The most frequently mutated novel loci were the activin type II receptor gene (58.1%), SEC63 (48.8%), AIM 2 (47.6%), a gene encoding a subunit of the NADH-ubiquinone oxidoreductase complex (27.9%), a homologue of mouse cordon-bleu (23.8%), and EBP1/PA2G4 (20.9%). This genome-wide approach identifies coding region MSI in genes or pathways not implicated previously in colorectal tumorigenesis, which may merit functional study or other additional analysis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11507051

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  49 in total

1.  Both microsatellite length and sequence context determine frameshift mutation rates in defective DNA mismatch repair.

Authors:  Heekyung Chung; Claudia G Lopez; Joy Holmstrom; Dennis J Young; Jenny F Lai; Deena Ream-Robinson; John M Carethers
Journal:  Hum Mol Genet       Date:  2010-04-23       Impact factor: 6.150

2.  Reassessing the TARBP2 mutation rate in hereditary nonpolyposis colorectal cancer.

Authors:  Pilar Garre; Pedro Pérez-Segura; Eduardo Díaz-Rubio; Trinidad Caldés; Miguel de la Hoya
Journal:  Nat Genet       Date:  2010-10       Impact factor: 38.330

Review 3.  Mismatch repair defects and Lynch syndrome: The role of the basic scientist in the battle against cancer.

Authors:  Christopher D Heinen
Journal:  DNA Repair (Amst)       Date:  2015-12-02

4.  Flanking nucleotide specificity for DNA mismatch repair-deficient frameshifts within activin receptor 2 (ACVR2).

Authors:  Heekyung Chung; Joy Chaudhry; Jenny F Lai; Dennis J Young; John M Carethers
Journal:  Mutat Res       Date:  2011-10-05       Impact factor: 2.433

5.  Activin type 2 receptor restoration in MSI-H colon cancer suppresses growth and enhances migration with activin.

Authors:  Barbara H Jung; Stayce E Beck; Jennifer Cabral; Eddy Chau; Betty L Cabrera; Antonio Fiorino; E Julieta Smith; Melanie Bocanegra; John M Carethers
Journal:  Gastroenterology       Date:  2006-11-16       Impact factor: 22.682

Review 6.  The PYRIN domain in signal transduction.

Authors:  Christian Stehlik
Journal:  Curr Protein Pept Sci       Date:  2007-06       Impact factor: 3.272

7.  Optimization of a pentaplex panel for MSI analysis without control DNA in a Brazilian population: correlation with ancestry markers.

Authors:  Nathália C Campanella; Gustavo N Berardinelli; Cristovam Scapulatempo-Neto; Danilo Viana; Edenir I Palmero; Rui Pereira; Rui M Reis
Journal:  Eur J Hum Genet       Date:  2013-11-06       Impact factor: 4.246

8.  ErbB3-binding protein 1 (EBP1) represses HNF4α-mediated transcription and insulin secretion in pancreatic β-cells.

Authors:  Eun Hee Han; Puja Singh; In-Kyu Lee; Raul Urrutia; Young-In Chi
Journal:  J Biol Chem       Date:  2019-07-30       Impact factor: 5.157

Review 9.  Role of AIM2 inflammasome in inflammatory diseases, cancer and infection.

Authors:  Bhesh Raj Sharma; Rajendra Karki; Thirumala-Devi Kanneganti
Journal:  Eur J Immunol       Date:  2019-08-14       Impact factor: 5.532

Review 10.  Molecular dissection of microsatellite instable colorectal cancer.

Authors:  Eduardo Vilar; Josep Tabernero
Journal:  Cancer Discov       Date:  2013-03-01       Impact factor: 39.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.